Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Optovue, founded in 2003 and headquartered in Fremont, California, is a privately-held medical device company specializing in optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) technologies. These advanced imaging systems are crucial for diagnosing and managing various eye diseases. The company has demonstrated its commitment to innovation in the ophthalmology field, having raised a total of $40.5 million in funding since its inception.
In a significant development, Optovue merged with Luneau Technology on September 22, 2021. This strategic move has potentially strengthened the company's market position and expanded its resources. However, it's important to note that we currently have no concrete information regarding Optovue's IPO prospects or plans to go public.
For investors interested in the medical device and ophthalmology sectors, Optovue's focus on cutting-edge OCT and OCTA technologies may be of particular interest. However, as the company remains private, opportunities to invest in Optovue stock or buy Optovue shares are not available through public markets at this time.
Given the lack of specific news or announcements regarding an Optovue IPO, it would be premature to speculate on any potential public offering. Factors that could influence such a decision in the future might include market conditions, the company's financial performance, and strategic goals following its merger with Luneau Technology. As always, potential investors should conduct thorough research and consider multiple factors before making any investment decisions.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Optovue's IPO prospects remain uncertain, investors interested in the medical imaging technology sector don't have to wait on the sidelines. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides opportunities to invest in potential industry leaders like Optovue, with lower minimum investments than traditional private equity channels. By leveraging our expertise, we help you diversify your portfolio with pre-IPO investments in innovative healthcare technology companies.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
